Product NDC: | 0115-1327 |
Proprietary Name: | Doxycycline Monohydrate |
Non Proprietary Name: | Doxycycline |
Active Ingredient(s): | 150 mg/1 & nbsp; Doxycycline |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0115-1327 |
Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200065 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110421 |
Package NDC: | 0115-1327-13 |
Package Description: | 60 CAPSULE in 1 BOTTLE (0115-1327-13) |
NDC Code | 0115-1327-13 |
Proprietary Name | Doxycycline Monohydrate |
Package Description | 60 CAPSULE in 1 BOTTLE (0115-1327-13) |
Product NDC | 0115-1327 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Doxycycline |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20110421 |
Marketing Category Name | ANDA |
Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Substance Name | DOXYCYCLINE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes |